Tribute Pharmaceuticals Overview
- Year Founded
-
1981
- Status
-
Acquired/Merged
- Employees
-
42
- Latest Deal Type
-
M&A
- Financing Rounds
-
10
- Investments
-
4
Tribute Pharmaceuticals General Information
Description
Manufacturer and seller of specialty pharmaceutical products created to offer treatment of recognized medical conditions and diseases. The company's specialty pharmaceutical products offers treatment in the field of cardiology, pain relief, dermatology, gastroenterology, women's health and other specialty products, enabling patients to cure their chronic diseases and stay healthy.
Contact Information
Website
www.tributepharma.comCorporate Office
- 151 Steeles Avenue East
- Milton, Ontario L9T 1Y1
- Canada
Corporate Office
- 151 Steeles Avenue East
- Milton, Ontario L9T 1Y1
- Canada
Tribute Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tribute Pharmaceuticals Comparisons
Industry
Financing
Details
Tribute Pharmaceuticals Competitors (10)
One of Tribute Pharmaceuticals’s 10 competitors is Chemo Holding, a Corporate Backed or Acquired company based in Madrid, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chemo Holding | Corporate Backed or Acquired | Madrid, Spain | ||||
| Paratek Pharmaceuticals | Private Equity-Backed | King of Prussia, PA | ||||
| 60 Degrees Pharma | Formerly VC-backed | Washington, DC | ||||
| Insud Pharma | Corporation | Madrid, Spain | ||||
| Melinta Therapeutics | Private Equity-Backed | Parsippany, NJ |
Tribute Pharmaceuticals Patents
Tribute Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2527664-T3 | Treatment of interstitial cystitis with a high dose of chondroitin sulfate | Inactive | 19-Feb-2003 |
Tribute Pharmaceuticals Signals
Tribute Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tribute Pharmaceuticals Investments & Acquisitions (4)
Tribute Pharmaceuticals’s most recent deal was a Merger/Acquisition with Medical Futures for . The deal was made on 17-Jun-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medical Futures | 17-Jun-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Fibricor (U.S. Rights) | 21-May-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Novartis (Canadian drug rights) | 03-Oct-2014 | Corporate Asset Purchase | Buildings and Property | ||
| Collatamp G | 20-Jun-2012 | Corporate Asset Purchase | Buildings and Property |
Tribute Pharmaceuticals FAQs
-
When was Tribute Pharmaceuticals founded?
Tribute Pharmaceuticals was founded in 1981.
-
Where is Tribute Pharmaceuticals headquartered?
Tribute Pharmaceuticals is headquartered in Milton, Canada.
-
What is the size of Tribute Pharmaceuticals?
Tribute Pharmaceuticals has 42 total employees.
-
What industry is Tribute Pharmaceuticals in?
Tribute Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Tribute Pharmaceuticals a private or public company?
Tribute Pharmaceuticals is a Private company.
-
What is the current valuation of Tribute Pharmaceuticals?
The current valuation of Tribute Pharmaceuticals is .
-
What is Tribute Pharmaceuticals’s current revenue?
The current revenue for Tribute Pharmaceuticals is .
-
How much funding has Tribute Pharmaceuticals raised over time?
Tribute Pharmaceuticals has raised $49.8M.
-
Who are Tribute Pharmaceuticals’s investors?
K2 & Associates Investment Management, Novelion Therapeutics, and SJ Strategic Investments have invested in Tribute Pharmaceuticals.
-
Who are Tribute Pharmaceuticals’s competitors?
Chemo Holding, Paratek Pharmaceuticals, 60 Degrees Pharma, Insud Pharma, and Melinta Therapeutics are some of the 10 competitors of Tribute Pharmaceuticals.
-
When was Tribute Pharmaceuticals acquired?
Tribute Pharmaceuticals was acquired on 05-Feb-2016.
-
Who acquired Tribute Pharmaceuticals?
Tribute Pharmaceuticals was acquired by Aralez Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process